Finance

Lists
9620:TADAWUL
Balsm Alofoq Medical Company CJSC
SAR 22,00
0,00%
(0,00) 1D
1 Okt., 14:02:52 GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 9620...
Mkt. cap
55,00 m
Avg. vol.
377,00
Volume
0,00
P/E ratio
38,51
52-wk high
SAR 54,20
52-wk low
SAR 22,00
EPS
SAR 0,57
Shares outstanding
912,50 k
Mkt. cap
55,00 m
Avg. vol.
377,00
Volume
0,00
P/E ratio
38,51
52-wk high
SAR 54,20
52-wk low
SAR 22,00
EPS
SAR 0,57
Shares outstanding
912,50 k
News stories
From web sources and news partners
About Balsm Alofoq Medical Company CJSC
CEO-
Employees-
Founded2012
Headquarters-
SectorHealth care provider
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
5,31 m
5,31 m
5,71 m
5,71 m
Cost of goods sold
3,55 m
3,55 m
3,98 m
3,98 m
Cost of revenue
3,55 m
3,55 m
3,98 m
3,98 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,25 m
1,25 m
1,40 m
1,40 m
Operating expense
1,22 m
1,22 m
1,40 m
1,40 m
Total operating expenses
4,77 m
4,77 m
5,39 m
5,39 m
Operating income
538,19 k
538,19 k
322,43 k
322,43 k
Other non operating income
-7,67 k
-7,67 k
148,26 k
148,26 k
EBT including unusual items
523,50 k
523,50 k
439,69 k
439,69 k
EBT excluding unusual items
523,50 k
523,50 k
439,69 k
439,69 k
Income tax expense
211,54 k
211,54 k
37,50 k
37,50 k
Effective tax rate
40,41%
40,41%
8,53%
8,53%
Other operating expenses
-
-
-
-
Net income
311,96 k
311,96 k
402,19 k
402,19 k
Net profit margin
5,88%
5,88%
7,04%
7,04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-7,02 k
-7,02 k
-31,00 k
-31,00 k
Net interest expenses
-7,02 k
-7,02 k
-31,00 k
-31,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
769,86 k
769,86 k
606,68 k
606,68 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme